[Skip to Navigation]
Sign In
Article
August 2005

Performance Limitations and Participation Restrictions Among Childhood Cancer Survivors Treated With Hematopoietic Stem Cell Transplantation: The Bone Marrow Transplant Survivor Study

Author Affiliations

Author Affiliations: Department of Pediatrics, University of Minnesota, Minneapolis (Drs Ness, Baker, Robison, and Gurney); and City of Hope National Medical Center, Duarte, Calif (Drs Bhatia, Forman, and Rosenthal, Mr Francisco, and Ms Carter).

Arch Pediatr Adolesc Med. 2005;159(8):706-713. doi:10.1001/archpedi.159.8.706
Abstract

Background  Hematopoietic stem cell transplantation (HCT) may result in important disease- and treatment-related late effects. This study estimated physical, emotional, and educational limitations (performance limitations) and restrictions in the ability to perform personal care or routine daily activities (physical participation restrictions) and restrictions in the ability to participate in social roles (social participation restrictions) in a cohort of cancer survivors treated with HCT during childhood.

Methods  Study participants included 235 persons who had a malignancy or hematologic disorder, were treated with HCT before the age of 21 years, and survived at least 2 years after transplantation. A comparison group was recruited and frequency matched for age, sex, and ethnicity. Medical data were abstracted, and patients or parents (if <18 years at survey completion) completed a mailed 24-page questionnaire.

Results  Adult survivors of childhood cancer were more likely than the comparison group to report limitations in physical (prevalence odds ratio [OR], 2.2; 95% confidence interval [CI], 1.3-3.7) and emotional domains (OR, 2.9; 95% CI, 1.4-5.8) and to report physical participation restrictions (OR, 3.9; 95% CI, 1.9-8.2). Adult survivors were also less likely than the comparison group to be married (OR, 0.4; 95% CI, 0.2-0.6). Child survivors were more likely than similarly aged children to have participated in special education (OR, 3.0; 95% CI, 1.5-6.0), to report physical participation restrictions (OR, 10.8; 95% CI, 2.2-53.9), and to have behaviors that indicated impaired social competence (OR, 2.0; 95% CI, 0.9-4.2).

Conclusion  This study demonstrated that persons treated with HCT as children were at increased risk for performance limitations that restricted participation in routine daily activities and interpersonal relationships.

Hematopoietic stem cell transplantation (HCT) is used to treat a variety of malignant and nonmalignant disorders in children and adults.1 Approximately 6000 HCTs are performed in the United States each year, with the number of recipients who are at least 5-year survivors estimated at 100 000.2 Hematopoietic stem cell transplantation is associated with several disease-related and treatment-specific medical late effects3-13 that have the potential to limit functional performance in physical, emotional, and educational domains. Over time, these limitations may adversely affect the individual’s ability to participate fully in life’s roles, such as engaging in daily activities or interacting socially.

Few studies of transplantation survivors have evaluated the prevalence of performance limitations across physical, emotional, and educational domains or the impact on the ability to participate physically and socially in life roles. Furthermore, few reports evaluate the association between performance limitations and participation restrictions in individuals who undergo transplantation during childhood.

The aims of this analysis were (1) to estimate the prevalence of performance limitations (physical, emotional, and educational) and physical and social participation restrictions in a cohort of patients who underwent transplantation before the age of 21 years and who survived at least 2 years after transplantation; (2) to compare performance limitations and participation restrictions in HCT survivors with those in a representative comparison group; and (3) to evaluate the extent to which performance limitations were associated with participation restrictions among HCT survivors.

Methods

Study population

This analysis is part of the Bone Marrow Transplant Survivor Study (BMT-SS), a collaborative study between City of Hope Cancer Center and the University of Minnesota. Eligibility criteria for this analysis included (1) HCT for hematologic or nonhematologic malignancy; (2) date of transplantation between January 1, 1974, and December 31, 1998; and (3) survival of more than 2 years after HCT. This analysis was restricted to English-speaking survivors younger than 21 years at the time of their transplantation and alive at the time of the initial survey. The human subjects review committees at both institutions approved all study questionnaires and protocols. All participants provided informed consent.

A total of 528 eligible patients were identified. Of these, 136 (25.7%) were lost to follow-up, 131 (24.8%) declined participation, and 26 (4.9%) had yet to complete the study questionnaire. A total of 235 survivors or their proxies completed a study questionnaire, which represents 60.0% of those successfully contacted. The comparison group included siblings of another cohort of cancer survivors14 who completed a questionnaire between 1996 and 2003 that contained identical study questions. Comparison group participants were frequency matched to cases at a ratio of 3:1 and randomly selected from 3845 eligible group members from within 6 age groups (<10 years, 11-14 years, 15-17 years, 18-29 years, 30-39 years, ≥40 years), 2 sex groups, and 2 race/ethnicity (white or other) categories.

Data collection

Data collection was conducted by abstracting information from medical records and by having participants (aged ≥18 years at survey) or their parents (if participants were aged <18 years) complete the 24-page BMT-SS questionnaire about the presence and timing of medical conditions, the presence of performance limitations during a 2-year period before study participation, and the presence of current participation restrictions. This questionnaire has excellent (93%)15 agreement with reported major medical conditions when compared with medical records information. Marital status, educational attainment, and a measure of emotional health, the Brief Symptom Inventory (BSI),16 are part of the adult version of the BMT-SS. Participation in special education, social competence, and emotional health based on parental observation are included in the child version of the BMT-SS.

Measures

Participation Restrictions

Adults. The primary outcome measures for adult participants treated during childhood were physical participation restrictions and marital status. Participants were classified as having a physical participation restriction if they answered yes to either of 2 questions: “Because of any impairment or health problems, do you need the help of other persons with personal care needs, such as eating, bathing, dressing, or getting around your home?” or “Because of any impairment or health problems, do you need the help of other persons in handling routine needs, such as everyday household chores, doing necessary business, shopping, or getting around for other purposes?” Marital status was determined by participants’ answers to the question, “Which of these possibilities best describes your current marital status?” A dichotomous value was assigned, in which 1 indicated married or living as married and 0 indicated unmarried.

Children. The primary outcome measures for younger participants were physical participation restrictions and social competence. Physical participation restrictions were classified as described for the adults. Social competence was scored by summing values from answers to 6 questions about current friendships and play behavior, adapted from the Child Behavior Checklist.17 Scores ranged from 4 (a child who had no friends, participated in few social activities, did not get along with others, and did not play well alone) to 19 (a child who had many friends, participated in multiple social activities, got along well with others, and could self-entertain). After examining the distributions of social competence, this variable was dichotomized using a cutoff point at or below the comparison group 10th percentile to represent social participation restrictions.

Performance Limitations

The risk factors of interest were limitations in physical, emotional, and educational performance.

Adults. Physical performance was scored by summing the answers to 6 questions about performance of particular physical activities: “Over the past 2 years, how long (if at all) has your health limited you in each of the following activities? (1) vigorous activities like lifting heavy objects, running, or participating in strenuous sports, (2) moderate activities like moving a table, carrying groceries, or bowling, (3) walking uphill or climbing a few flights of stairs, (4) bending, lifting, or stooping, (5) walking one block, and (6) eating, dressing, bathing, or using the toilet.” Scores of 1 to 3 were assigned to each question, with 1 indicating limited for more than 3 months; 2, limited for 3 months or less; and 3, not limited at all. This variable was also dichotomized using a cut point at or below the comparison group 10th percentile to indicate the presence of physical performance limitations. Emotional functioning was evaluated by scoring the BSI-18, an instrument designed to evaluate emotional health. Raw scores were converted to T scores based on population normative values provided in the scoring manual.16 On the basis of previous work by Derogatis,16 a T score of 63 or higher was used as the cutoff point for impaired emotional health. Educational attainment was classified according to participants’ answers to the question, “What is the highest grade or level of schooling that you have completed?” Participants were classified into 3 categories: (1) did not complete high school, (2) high school graduate, and (3) college graduate.

Children. Physical performance among children was scored as described for adults. Children’s emotional functioning was evaluated using a score based on 23 behavior questions answered by the child’s parent. The construct validity of this portion of the questionnaire was evaluated in a larger population of childhood cancer survivors14 using exploratory factor analysis, in which 5 factors were identified with maximum likelihood estimation. The correlations of the questions within and between each factor were identified to determine internal consistency. The mean values between participants and siblings were compared to evaluate discriminate validity (within-factor and between-factor correlations ranged from 0.75 to 0.89; survivors had higher scores than siblings, indicating greater problems with behaviors related to emotional health; P<.001). This variable was dichotomized using a cutoff point at or above the comparison group 90th percentile to indicate the presence of emotional performance limitations. Participation in special education was used as a crude measure of educational attainment among younger participants, recorded as a dichotomous variable based on the answer of the child’s proxy to the question, “In elementary, junior high, or high school, was your child ever in a learning disabled or special education program because of low scores on tests, problems learning or concentrating, emotional-behavioral problems, or missed school?”

Transplantation-Related Variables and Medical Late Effects

Graft-vs-host Disease and Major Medical Conditions. The presence of chronic graft-vs-host disease (cGVHD) was determined by examining medical records. Consistent with the work of Hudson et al,18 the following major medical late effects, reported by survivors since transplantation, were analyzed: complete deafness; kidney dialysis; congestive heart failure; a history of myocardial infarction; angioplasty; bypass surgery or stroke; liver cirrhosis; heart, lung, or kidney transplantation; amputation; joint replacement or a second cancer; and current use of seizure medications, medications for heart problems or high blood pressure, chemotherapy, immunosuppressants, or oxygen.18

Personal Characteristics. Personal characteristics included study participants’ sex, race/ethnicity, age in years at survey completion, and age at transplantation, and time since transplantation.

Statistical analyses

All analyses were completed separately for participants younger than 18 years (children) at the time of the survey and those who were 18 years or older (adults). The analyses of educational attainment and marital status for adults were stratified into 2 groups to account for the possibility that 18- to 24-year-old survivors might still be completing formal education.

The HCT survivors were compared with the comparison group for the presence of a major medical condition, for each performance measure (physical, emotional, and educational), for physical participation restrictions and marital status (adults), or for physical and social participation restrictions (children) using multiple logistic regression. Restricting the analyses to the HCT survivor population only, logistic regression models were used to evaluate the association between the participants’ personal characteristics, conditioning regimen, cGVHD, or a major medical condition among HCT survivors who reported physical, emotional, and educational performance limitations. Finally, to determine the relation between measures of performance and the outcome variables of physical participation restrictions, marital status (adults), and social participation restrictions (children), each measure of performance was evaluated in survivor-survivor comparisons using multiple logistic regression, adjusting for sex, ethnicity, time since transplantation in years, and age at survey completion.

Results

Participant characteristics

Participants were more likely than nonparticipants to be female (104 [44.3%] and 91 [34.1%], respectively) and white (199 [84.7%] vs 205 [76.8%]) but did not otherwise differ significantly from nonparticipants (Table 1). The mean age at survey completion was similar for the adult participants and the adult comparison group (mean ± SD, 26 ± 6 years). Among the children, both participants and members of the comparison group had mean ± SD ages of 13 ± 3 years. Mean age at transplantation was 10.7 ± 6.3 years, and mean survival time was 11.7 ± 5.7 years. The diagnosis and treatment characteristics of the study participants are given in Table 2.

Table 1. 
Comparison of Study Participants and Eligible Nonparticipants
Comparison of Study Participants and Eligible Nonparticipants
Table 2. 
Characteristics of the Study Participants and Comparison Groups
Characteristics of the Study Participants and Comparison Groups

Survivor–comparison group analyses

Major Medical Conditions

Adults. We documented cGVHD in 37 (23.4%) of participants. Fifteen (9.5%) of adults reported current use of cardiac medications, and 15 (9.5%) reported current use of immunosuppressants. The other most common medical conditions reported by adults were a history of second cancer (14 [8.9%]) or stroke (9 [5.7%]). The HCT recipients were 10.3 times (95% confidence interval [CI], 6.1-17.4) more likely to report a major medical condition than were adults in the comparison group (data not shown).

Children. Nine (11.5%) of young survivors had documented cGVHD. Current use of cardiac medications was reported for 12 of children (15.4%), and current use of immunosuppressants was reported for 4 (5.1%). The other most common medical condition was congestive heart failure (4 children [5.1%]). Child survivors were 24.8 times (95% CI, 7.1-86.6) more likely to have a reported major medical condition than children in the comparison group (data not shown).

Performance Limitations and Participation Restrictions

Adults. Limitations in physical performance were reported by 28 (17.8%) of adult survivors compared with 42 adults (8.9%) in the comparison group (odds ratio [OR], 2.2; 95% CI, 1.3-3.7). Adult survivors were almost 3 times (OR, 2.9; 95% CI, 1.4-5.8) more likely to have a BSI score that indicated an emotional difficulty. No significant differences in educational attainment were observed. Adult survivors were 3.9 times (95% CI, 1.9-8.2) more likely to report physical participation restrictions than the comparison group (Table 3).

Table 3. 
Performance Limitations and Participation Restrictions Among Survivors of Childhood HCT and Comparison Group
Performance Limitations and Participation Restrictions Among Survivors of Childhood HCT and Comparison Group

Children. Limitations in physical and emotional performance did not differ significantly between survivors and the comparison group, although HCT survivors were 3.0 times (95% CI, 1.5-6.0) more likely to have participated in special education. The HCT survivors were also more likely than the comparison group to report a physical participation restriction (9.0% vs 0.8%; OR, 10.8; 95% CI, 2.2-53.9) and were twice as likely to have reported behaviors that indicated social participation restrictions (Table 3).

Survivor-survivor analysis

Performance Limitations

Adults. Adult survivors with physical performance limitations were more likely to have documented cGVHD (OR, 3.1; 95% CI, 1.3-7.5) or a reported major medical condition (OR, 3.4; 95% CI, 1.4-7.9) than those without physical performance limitations, after adjusting for age at interview and sex. Emotional performance limitations were not associated with any particular treatment variables or medical late effects. Adult survivors of races other than white were less likely than white survivors to graduate from high school (Table 4).

Table 4. 
Association Among Performance Limitations, Participant Characteristics, Chronic Graft-vs-host Disease, and Major Medical Condition Among Survivors of Childhood HCT
Association Among Performance Limitations, Participant Characteristics, Chronic Graft-vs-host Disease, and Major Medical Condition Among Survivors of Childhood HCT

Children. After adjusting for sex, age at transplantation, cGVHD, and the presence of a major medical condition, the relative odds of a physical performance limitation were higher among the HCT survivors who had received total body irradiation (TBI) (OR, 15.9; 95% CI, 1.3-199.4) when compared with survivors who did not receive TBI. A strong association was also seen among those who were more than 10 years past diagnosis (OR, 31.7; 95% CI, 1.2-812.1) relative to those who had survived 2 to 5 years. Emotional performance limitations and participation in special education were not associated with any particular personal characteristic, treatment regimen, or medical late effect in children (Table 4).

Participation Restrictions and Performance Limitations

Adults. The impact of the loss of performance on participation is given in Table 5. After adjusting for age at survey, time since transplantation, sex, and race/ethnicity, all domains of the performance limitations were associated with restricted abilities to perform personal care or to participate in routine activities among adult survivors of childhood HCT. Adult survivors with physical performance limitations were 22.1 times (95% CI, 6.3-77.9) more likely to need help with personal care or routine activities than those without physical performance limitations. Those with emotional performance limitations were 17.1-fold more likely (95% CI, 4.6-64.0) to report physical participation restrictions than those without, and participants who did not graduate from high school were 4.7 times (95% CI, 1.1-21.0) more likely than those who graduated from high school to report physical participation restrictions. Adult HCT survivors were 5 times less likely than those without physical performance limitations to be currently married (OR, 0.2; 95% CI, 0.1-0.9).

Association Between Participation Restriction and Performance Limitation Among Survivors of Childhood HCT
Association Between Participation Restriction and Performance Limitation Among Survivors of Childhood HCT

Children. Limitations in physical and emotional performance and the need for special education were associated with both physical and social participation restrictions in young HCT survivors (Table 5). Children with emotional performance limitations were 9.2 times (95% CI, 1.2-68.0) more likely than those without to have a physical participation restriction. These children were also far less able to participate socially, having 83.3 times (95% CI, 9.9-698.7) the risk of scoring within the lowest 10% of population norms when compared with children without an emotional performance limitation.

Comment

This study demonstrates that 10% of long-term HCT survivors who underwent transplantation during childhood report a physical participation restriction that limits independence in personal care or routine activities, a significantly higher proportion than found in a comparison group of similar sex and age. Although few quantitative studies of physical and social participation restrictions in individuals who received HCT as children exist, our findings support previous work in the adult HCT population, where the prevalence of physical participation restrictions has been estimated at 9.5% to 26.3%.19-21 In our relatively young adult population, the proportion of survivors married or living as married was also lower (26.8%) than reported by other researchers in populations of survivors who received HCT during adulthood (57.0%-71.0%).22-25 Among child participants in our study, 16.7% had a reported difficulty with social skills. Another recent study26 of childhood HCT survivors reported an even higher proportion (25.0%) who indicated difficulty with social skills.

In our study, physical participation restrictions and not being in a marital relationship were significantly associated with physical performance limitations, independent of effects of age, length of survival, sex, and race/ethnicity. Physical performance limitations were most common in young adult HCT survivors who had a major medical condition, cGVHD, or both. These findings are consistent with much of the literature related to late effects and quality of life in HCT recipients, which shows that physical symptoms and physical performance limitations continue to be a problem for a small proportion of long-term survivors.3,19,27-34

Among the child HCT survivors, our study demonstrated that physical and social participation restrictions were associated with limitations in physical and emotional performance and with the need for special education. Children who received TBI as part of their conditioning regimen were more likely to have impaired physical performance. Limitations in physical performance were more common in children with a longer survival time, perhaps indicating the loss of function over time. There is little information available about the effects of TBI on physical performance; however, TBI was previously reported to be associated with limitations in cognitive functioning in childhood HCT recipients.35,36 Recent studies indicate that cognitive decline may not become apparent until later in the child’s development.37

Methodologic limitations need to be considered when interpreting these results. First, given the relatively low response rate (60% of those successfully contacted), the possibility exists that participation bias influenced our estimates. Participants did not differ from nonparticipants by most sociodemographic or treatment factors, but we could not assess differences in medical late effects, performance limitations, or participation status. Second, our comparison group consisted of siblings of cancer survivors who are by nature indirect participants in the cancer experience and could conceivably have uncommonly high frequencies of performance limitations in the emotional or educational domains.38,39 Third, sample size restrictions did not allow us to provide reliable statistical estimates of outcomes by type of cancer, specific conditioning regimen, transplantation type, or stem cell source. Fourth, the survey for the younger participants was completed by their parents, who may have expectations and interpretations that differ from those of their children in terms of both emotional performance and participation in social situations. Finally, because the data regarding medical late effects, performance limitations, and participation restrictions were collected simultaneously, we cannot be certain about the temporal association among these outcomes.

This study represents the first attempt, to our knowledge, to report in a comprehensive and systematic fashion the participation restrictions experienced by long-term cancer survivors who underwent transplantation during childhood. We have shown in this study that although most survivors lead independent and productive lives, a subset of individuals have persistent medical late effects or organ system impairments that result in performance limitations associated with impaired social skills, decreased physical independence, and decreased rates of marriage. Surveillance and long-term follow-up should include monitoring of children and adults treated during childhood who are at risk for functional loss so that they can be referred for intervention to restore function, provide compensatory strategies for function that cannot be restored, or adapt the environment to allow optimal participation in home and social environments.40,41

Correspondence: James G. Gurney, PhD, Division of General Pediatrics, University of Michigan, 300 N Ingalls, Room 6E08, Ann Arbor, MI 48109-0456 (jamegurn@umich.edu).

Back to top
Article Information

Accepted for Publication: February 17, 2005.

Funding/Support: This study was supported by grant CA78938-02 from the National Institutes of Health, Bethesda, Md. Dr Bhatia is a Clinical Scholar of the Leukemia and Lymphoma Society, White Plains, NY. Dr Gurney receives support from the Children’s Cancer Research Fund at the University of Minnesota.

References
1.
Horowitz  MM Uses and growth of hematopoietic cell transplantation. Blume  KGForman  SJAppelbaum  FReds. Thomas' Hematopoietic Cell Transplantation 3rd ed. Malden, Mass Blackwell Publishing2004;9- 15Google Scholar
2.
Socie  GStone  JVWingard  JR  et al. Late Effects Working Committee of the International Bone Marrow Transplant Registry, Long-term survival and late deaths after allogeneic bone marrow transplantation.  N Engl J Med 1999;34114- 21PubMedGoogle ScholarCrossref
3.
Duell  Tvan Lint  MTLjungman  P  et al. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects; European Group for Blood and Marrow Transplantation, Health and functional status of long-term survivors of bone marrow transplantation.  Ann Intern Med 1997;126184- 192PubMedGoogle ScholarCrossref
4.
Socie  GStone  JVWingard  JR  et al. Late Effects Working Committee of the International Bone Marrow Transplant Registry, Long-term survival and late deaths after allogeneic bone marrow transplantation.  N Engl J Med 1999;34114- 21PubMedGoogle ScholarCrossref
5.
Flowers  MEDDeeg  HJ Delayed complications after hematopoietic cell transplantation. Blume  KGForman  SJAppelbaum  EReds. Thomas' Hematopoietic Cell Transplantation 3rd ed. Malden, Mass Blackwell Publishing2004;944- 961Google Scholar
6.
Guinan  ECKrance  RALehmann  LF Stem cell transplantation in pediatric oncology. Pizzo  PAPolack  DGeds. Principles and Practice of Pediatric Oncology 4th ed. Philadelphia, Pa Lippincott Williams & Wilkins2000;429- 452Google Scholar
7.
Cool  VA Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know?  Bone Marrow Transplant 1996;18 ((suppl 3)) S45- S49PubMedGoogle Scholar
8.
Kramer  JHCrittenden  MRDeSantes  KCowan  MJ Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation.  Bone Marrow Transplant 1997;19607- 613PubMedGoogle ScholarCrossref
9.
Phipps  SDunavant  MSrivastava  DKBowman  LMulhern  RK Cognitive and academic functioning in survivors of pediatric bone marrow transplantation.  J Clin Oncol 2000;181004- 1011PubMedGoogle Scholar
10.
Andrykowski  MAAltmaier  EMBarnett  RLBurish  TGGingrich  RHenslee-Downey  PJ Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation.  Bone Marrow Transplant 1990;6269- 276PubMedGoogle Scholar
11.
Meyers  CAWeitzner  MByrne  KValentine  AChamplin  REPrzepiorka  D Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.  J Clin Oncol 1994;12820- 826PubMedGoogle Scholar
12.
Peper  MSteinvorth  SSchraube  P  et al.  Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors.  Int J Radiat Oncol Biol Phys 2000;46303- 311PubMedGoogle ScholarCrossref
13.
Harder  HCornelissen  JJVan Gool  ARDuivenvoorden  HJEijkenboom  WMvan den Bent  MJ Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.  Cancer 2002;95183- 192PubMedGoogle ScholarCrossref
14.
Robison  LLMertens  ACBoice  JD  et al.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.  Med Pediatr Oncol 2002;38229- 239PubMedGoogle ScholarCrossref
15.
Louie  ADRobison  LLBogue  MHyde  SForman  SJBhatia  S Validation of self-reported complications by bone marrow transplantation survivors.  Bone Marrow Transplant 2000;251191- 1196PubMedGoogle ScholarCrossref
16.
Derogatis  LR Brief Symptom Inventory (BSI) 18, Administration, Scoring, and Procedures Manual.  Minneapolis, Minn NCS Pearson Inc2000;
17.
Achenbach  TMRuffle  TM The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies.  Pediatr Rev 2000;21265- 271PubMedGoogle ScholarCrossref
18.
Hudson  MMMertens  ACYasui  Y  et al.  Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.  JAMA 2003;2901583- 1592PubMedGoogle ScholarCrossref
19.
Broers  SKaptein  AALe Cessie  SFibbe  WHengeveld  MW Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study.  J Psychosom Res 2000;4811- 21PubMedGoogle ScholarCrossref
20.
Bush  NEHaberman  MDonaldson  GSullivan  KM Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation.  Soc Sci Med 1995;40479- 490PubMedGoogle ScholarCrossref
21.
Molassiotis  ABoughton  BJBurgoyne  Tvan den Akker  OB Comparison of the overall quality of life in 50 long-term survivors of autologous and allogeneic bone marrow transplantation.  J Adv Nurs 1995;22509- 516PubMedGoogle ScholarCrossref
22.
Prieto  JMSaez  RCarreras  E  et al.  Physical and psychosocial functioning of 117 survivors of bone marrow transplantation.  Bone Marrow Transplant 1996;171133- 1142PubMedGoogle Scholar
23.
Belec  RH Quality of life: perceptions of long-term survivors of bone marrow transplantation.  Oncol Nurs Forum 1992;1931- 37PubMedGoogle Scholar
24.
Baker  FCurbow  BWingard  JR Role retention and quality of life of bone marrow transplant survivors.  Soc Sci Med 1991;32697- 704PubMedGoogle ScholarCrossref
25.
Sutherland  HJFyles  GMAdams  G  et al.  Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.  Bone Marrow Transplant 1997;191129- 1136PubMedGoogle ScholarCrossref
26.
Nespoli  LVerri  APLocatelli  FBertuggia  LTaibi  RMBurgio  GR The impact of paediatric bone marrow transplantation on quality of life.  Qual Life Res 1995;4233- 240PubMedGoogle ScholarCrossref
27.
Felder-Puig  RPeters  CMatthes-Martin  S  et al.  Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation.  Bone Marrow Transplant 1999;2475- 80PubMedGoogle ScholarCrossref
28.
Hjermstad  MJEvensen  SAKvaloy  SOFayers  PMKaasa  S Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.  J Clin Oncol 1999;17706- 718PubMedGoogle Scholar
29.
Heinonen  HVolin  LUutela  AZevon  MBarrick  CRuutu  T Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation.  Ann Hematol 2001;80137- 143PubMedGoogle ScholarCrossref
30.
Bush  NEDonaldson  GWHaberman  MHDacanay  RSullivan  KM Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients.  Biol Blood Marrow Transplant 2000;6576- 591PubMedGoogle ScholarCrossref
31.
Kiss  TLAbdolell  MJamal  NMinden  MDLipton  JHMessner  HA Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation.  J Clin Oncol 2002;202334- 2343PubMedGoogle ScholarCrossref
32.
Chiodi  SSpinelli  SRavera  G  et al.  Quality of life in 244 recipients of allogeneic bone marrow transplantation.  Br J Haematol 2000;110614- 619PubMedGoogle ScholarCrossref
33.
Lee  SJFairclough  DParsons  SK  et al.  Recovery after stem-cell transplantation for hematologic diseases.  J Clin Oncol 2001;19242- 252PubMedGoogle Scholar
34.
Syrjala  KLChapko  MKVitaliano  PPCummings  CSullivan  KM Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning.  Bone Marrow Transplant 1993;11319- 327PubMedGoogle Scholar
35.
Smedler  ACBolme  P Neuropsychological deficits in very young bone marrow transplant recipients.  Acta Paediatr 1995;84429- 433PubMedGoogle ScholarCrossref
36.
Smedler  ACNilsson  CBolme  P Total body irradiation: a neuropsychological risk factor in pediatric bone marrow transplant recipients.  Acta Paediatr 1995;84325- 330PubMedGoogle ScholarCrossref
37.
Sattler  J Assessment of Children. 4th ed. San Diego, Calif Jerome M. Sattler2001;
38.
Sahler  OJRoghmann  KJCarpenter  PJ  et al.  Sibling adaptation to childhood cancer collaborative study: prevalence of sibling distress and definition of adaptation levels.  J Dev Behav Pediatr 1994;15353- 366PubMedGoogle ScholarCrossref
39.
Sloper  PWhile  D Risk factors in the adjustment of siblings of children with cancer.  J Child Psychol Psychiatry 1996;37597- 607PubMedGoogle ScholarCrossref
40.
Dimeo  FBertz  HFinke  JFetscher  SMertelsmann  RKeul  J An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation.  Bone Marrow Transplant 1996;181157- 1160PubMedGoogle Scholar
41.
Wingard  JR Quality of life following bone marrow transplantation.  Curr Opin Oncol 1998;10108- 111PubMedGoogle ScholarCrossref
×